Carmen Vigo‐Pelfrey

8.8k total citations · 5 hit papers
18 papers, 7.3k citations indexed

About

Carmen Vigo‐Pelfrey is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Carmen Vigo‐Pelfrey has authored 18 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Carmen Vigo‐Pelfrey's work include Alzheimer's disease research and treatments (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Dementia and Cognitive Impairment Research (5 papers). Carmen Vigo‐Pelfrey is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Dementia and Cognitive Impairment Research (5 papers). Carmen Vigo‐Pelfrey collaborates with scholars based in United States, Sweden and Austria. Carmen Vigo‐Pelfrey's co-authors include Ivan Lieberburg, Dennis J. Selkoe, Dale Schenk, Albert Y. Hung, Christian Haass, Peter Seubert, Martin Citron, David B. Teplow, Lisa McConlogue and Tilman Oltersdorf and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Carmen Vigo‐Pelfrey

18 papers receiving 7.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid β-peptide is produced by cultured cells during normal metabolism

1992 1.6k citations Christian Haass, Michael G. Schlossmacher et al. Nature profile →
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

1992 1.5k citations Peter Seubert, Carmen Vigo‐Pelfrey et al. Nature profile →
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

1992 1.4k citations Martin Citron, Tilman Oltersdorf et al. Nature profile →
Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

1995 568 citations Ruth Motter, Carmen Vigo‐Pelfrey et al. Annals of Neurology profile →
Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains

1996 516 citations Yu‐Min Kuo, Mark R. Emmerling et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Vigo‐Pelfrey United States	18	6.1k	3.5k	1.5k	1.1k	1.0k	18	7.3k
Jan Näslund Sweden	30	5.4k 0.9×	3.4k 1.0×	1.4k 0.9×	1.0k 0.9×	1.0k 1.0×	51	7.0k
Marcia B. Podlisny United States	30	5.4k 0.9×	3.2k 0.9×	1.3k 0.9×	837 0.8×	1.1k 1.1×	38	6.2k
Caine W. Wong United States	8	4.8k 0.8×	3.0k 0.9×	1.1k 0.7×	781 0.7×	935 0.9×	9	6.0k
Dennis J. Selkoe United States	15	4.8k 0.8×	3.2k 0.9×	1.3k 0.9×	898 0.8×	1.2k 1.1×	17	6.4k
G. Simms Australia	5	4.5k 0.7×	2.7k 0.8×	866 0.6×	696 0.6×	766 0.7×	6	5.3k
Lisa McConlogue United States	31	6.0k 1.0×	3.6k 1.0×	1.7k 1.1×	1.1k 1.0×	2.2k 2.1×	41	8.2k
Stephen D. Schmidt United States	30	5.6k 0.9×	2.8k 0.8×	1.3k 0.9×	802 0.7×	1.2k 1.2×	38	7.4k
Mary Jo LaDu United States	51	7.1k 1.2×	3.8k 1.1×	1.3k 0.9×	962 0.9×	2.0k 1.9×	105	9.6k
Nikolaos K. Robakis United States	51	4.3k 0.7×	4.1k 1.2×	1.1k 0.8×	516 0.5×	1.6k 1.6×	133	7.3k
K Beyreuther Australia	6	4.0k 0.6×	2.4k 0.7×	817 0.6×	681 0.6×	679 0.7×	8	5.2k

Countries citing papers authored by Carmen Vigo‐Pelfrey

Since Specialization

Citations

This map shows the geographic impact of Carmen Vigo‐Pelfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Vigo‐Pelfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Vigo‐Pelfrey more than expected).

Fields of papers citing papers by Carmen Vigo‐Pelfrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Vigo‐Pelfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Vigo‐Pelfrey. The network helps show where Carmen Vigo‐Pelfrey may publish in the future.

Co-authorship network of co-authors of Carmen Vigo‐Pelfrey

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Vigo‐Pelfrey. A scholar is included among the top collaborators of Carmen Vigo‐Pelfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Vigo‐Pelfrey. Carmen Vigo‐Pelfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Höck, Christoph, Sidonie Golombowski, F. Müller‐Spahn, et al.. (1998). Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity. European Neurology. 39(2). 111–118. 73 indexed citations

Aksenov, Michael Y., Marina Aksenova, D. Allan Butterfield, et al.. (1996). Glutamine Synthetase‐Induced Enhancement of β‐Amyloid Peptide Aβ(1–40) Neurotoxicity Accompanied by Abrogation of Fibril Formation and Aβ Fragmentation. Journal of Neurochemistry. 66(5). 2050–2056. 49 indexed citations

Kuo, Yu‐Min, Mark R. Emmerling, Carmen Vigo‐Pelfrey, et al.. (1996). Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains. Journal of Biological Chemistry. 271(8). 4077–4081. 516 indexed citations breakdown →

Vigo‐Pelfrey, Carmen, Peter Seubert, Robin Barbour, et al.. (1995). Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 45(4). 788–793. 185 indexed citations

Nitsch, Roger M., G. William Rebeck, Meihua Deng, et al.. (1995). Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype. Annals of Neurology. 37(4). 512–518. 94 indexed citations

Lannfelt, Lars, Hans Basun, Carmen Vigo‐Pelfrey, et al.. (1995). Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neuroscience Letters. 199(3). 203–206. 33 indexed citations

Motter, Ruth, Carmen Vigo‐Pelfrey, Dora Kholodenko, et al.. (1995). Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 38(4). 643–648. 568 indexed citations breakdown →

Lieberburg, Ivan, et al.. (1995). Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. Journal of Neuroscience. 15(7). 4896–4905. 39 indexed citations

Johnston, Janet, Richard F. Cowburn, Svante Norgren, et al.. (1994). Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Letters. 354(3). 274–278. 112 indexed citations

10.

Citron, Martin, Carmen Vigo‐Pelfrey, David B. Teplow, et al.. (1994). Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.. Proceedings of the National Academy of Sciences. 91(25). 11993–11997. 272 indexed citations

11.

Lang, Johanna K. & Carmen Vigo‐Pelfrey. (1993). Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol. Chemistry and Physics of Lipids. 64(1-3). 19–29. 22 indexed citations

12.

Vigo‐Pelfrey, Carmen, et al.. (1993). Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid. Journal of Neurochemistry. 61(5). 1965–1968. 340 indexed citations

13.

Ma, Bo, Bea Christen, Danny T. M. Leung, & Carmen Vigo‐Pelfrey. (1992). Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. Journal of Clinical Microbiology. 30(2). 370–376. 119 indexed citations

14.

Haass, Christian, Michael G. Schlossmacher, Albert Y. Hung, et al.. (1992). Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359(6393). 322–325. 1606 indexed citations breakdown →

15.

Seubert, Peter, Carmen Vigo‐Pelfrey, Fred Esch, et al.. (1992). Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359(6393). 325–327. 1454 indexed citations breakdown →

16.

Citron, Martin, Tilman Oltersdorf, Christian Haass, et al.. (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature. 360(6405). 672–674. 1395 indexed citations breakdown →

17.

Lång, Johanna, Carmen Vigo‐Pelfrey, & Francis J. Martin. (1990). Liposomes composed of partially hydrogenated egg phosphatidylcholines: fatty acid composition, thermal phase behavior and oxidative stability. Chemistry and Physics of Lipids. 53(1). 91–101. 39 indexed citations

18.

Vigo‐Pelfrey, Carmen. (1990). Membrane lipid oxidation. Free Radical Biology and Medicine. 9(5). 455–456. 335 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact